07/28/2026
We're honored to be named to the Forbes Next Billion-Dollar Startups list, Forbes' annual selection of 20 fast-growing U.S. companies it considers most likely to reach a $1 billion valuation.
Ten years ago, co-founders Kevin Caldwell and Erik Woods set out to prove that bone marrow from organ donors could be recovered, cryopreserved, and made available to patients on demand. Today, 28 patients have received transplants with bone marrow from Ossium’s bank.
This recognition belongs to our team, our clinical partners, and the donor families whose gift makes every one of these transplants possible.
The Forbes Next Billion-Dollar Startups 2026 list highlights venture-backed companies likely to become unicorns. Learn more about these fast-growing startups.